Articles From: Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry Date to Helmerich & Payne, Inc. Announces Third Quarter Earnings


http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1041784&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry Date investment picks
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1063616&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Announces Fiscal 2013 Results investment picks
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1076296&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Announces Fiscal Q1 2014 Results investment picks
2014/3/14
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1098226&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Announces Fiscal Q2 2014 Results investment picks
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1062913&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Announces the Receipt of Subscription Agreements for a Net CDN$4.6 Million Private Placement investment picks
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1046413&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Establishes Polish Subsidiary investment picks
2014/4/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1104627&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Initiates Enrollment for Eighth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47 investment picks
http://media.marketwire.com/attachments/201010/14430_helixbiopharmalogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1055047&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Initiates Enrollment for Fifth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47 investment picks
2014/2/18
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1090955&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Initiates Enrollment for Seventh Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47 investment picks
2014/1/22
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1083977&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Initiates Enrollment for Sixth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47 investment picks
2014/4/3
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1104058&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. Submits L-DOS47 Investigational New Drug Application With U.S. Food and Drug Administration investment picks
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1049046&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. to Conduct Interim Review of Its LDOS002 Phase I/II Clinical Study investment picks
http://media.marketwire.com/attachments/201010/14433_helixbiopharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1048568&ProfileId=051205&sourceType=1 AURORA, ON --
Sign-up for Helix BioPharma Corp. to Present at Rodman & Renshaw Annual Global Investment Conference investment picks
2014/2/19
Helix Energy Solutions Group, Inc. (NYSE: HLX) reported net income of $36.5 million, or $0.35 per diluted share, for the fourth quarter of 2013 compared to a net loss of $171.6 million, or $(1.64) per diluted share, for the same period in 2012, and net income of $44.6 million, or $0.42 per diluted share, in the third quarter of 2013.
Sign-up for Helix Reports Fourth Quarter and Full Year 2013 Results investment picks
2013/10/21
Helix Energy Solutions Group, Inc. (NYSE: HLX) reported net income of $44.6 million, or $0.42 per diluted share, for the third quarter of 2013 compared to net income of $14.9 million, or $0.14 per diluted share, for the same period in 2012, and $27.2 million, or $0.26 per diluted share, in the second quarter of 2013.
Sign-up for Helix Reports Third Quarter 2013 Results investment picks
Helix Energy Solutions Group, Inc. (NYSE: HLX) announced today that it has signed a contract with Sembcorp Marine’s subsidiary Jurong Shipyard in Singapore for the construction of its Q7000 newbuild semisubmersible well intervention vessel previously announced by Helix in July.
Sign-up for Helix Signs Agreement with Sembcorp Marine’s Jurong Shipyard to Build Q7000 Semisubmersible Well Intervention Vessel investment picks
Helix Energy Solutions Group, Inc. (NYSE: HLX) announced it will be presenting at the following conferences for the remainder of 2013: Live audio feed and replay of the Jefferies and Capital One conference presentations will be publicly available.
Sign-up for Helix to Present at Three Upcoming Conferences investment picks
Helix Energy Solutions Group, Inc. (NYSE:HLX) announced it will be presenting at the following conferences: Live audio feed and replay of both conferences will be publicly available.
Sign-up for Helix to Present at Upcoming Conferences investment picks
2014/2/18
Helix Energy Solutions Group, Inc. (NYSE: HLX) announced it will be presenting at the following conferences over the next few weeks: Live audio feed and replay of the Raymond James conference presentation will be publicly available.
Sign-up for Helix to Present at Upcoming Conferences investment picks
Helix Energy Solutions Group, Inc. (NYSE: HLX) announced it will be presenting at the following conferences in August 2013: The presentations may be accessed under the “ For The Investor ” section of Helix’s website, www.HelixESG.com .
Sign-up for Helix to Present at Upcoming Conferences in August investment picks
Helix Energy Solutions Group, Inc. (NYSE: HLX) announced today that it is upgrading its 2013 EBITDA guidance to approximately $290 – $300 million.
Sign-up for Helix Updates 2013/14 Outlook investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0896605001&sourceType=1 http://www.ccnmatthews.com/logos/20100915-hellix2.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for Hellix Drops Margarita Lease investment picks
By Lizette Chapman Hellman & Friedman has purchased educational analytics company Renaissance Learning Inc. from European private equity firm Permira for $1.1 billion.
Sign-up for Hellman & Friedman To Acquire Renaissance Learning -- Update investment picks
By Lizette Chapman Hellman & Friedman has purchased educational analytics company Renaissance Learning Inc. from European private-equity firm Permira for $1.1 billion.
Sign-up for Hellman & Friedman to Acquire Renaissance Learning for $1.1 Billion investment picks
Hellman & Friedman has purchased educational analytics company Renaissance Learning Inc. from European private equity firm Permira for $1.1 billion.
Sign-up for Hellman & Friedman to Buy Renaissance Learning investment picks
2014/3/5
TULSA, Okla., March 5, 2014 (GLOBE NEWSWIRE) -- Helmerich & Payne, Inc. (NYSE:HP) confirmed today that the Company has entered into new drilling contracts with YPF Sociedad Anonima (NYSE:YPF) .
Sign-up for Helmerich & Payne Announces Contract Awards in Argentina investment picks
2014/1/30
TULSA, Okla., Jan.
Sign-up for Helmerich & Payne, Inc. Announces First Quarter Results and Additional New Build Contracts investment picks
2013/11/14
TULSA, Okla., Nov.
Sign-up for Helmerich & Payne, Inc. Announces Record Fiscal Year-End Results and Additional New Build Contracts investment picks
2013/7/26
TULSA, Okla., July 26, 2013 (GLOBE NEWSWIRE) -- Helmerich & Payne, Inc. (NYSE:HP) reported income from continuing operations of $250,978,000 ($2.32 per diluted share) from operating revenues of $840,197,000 for its third fiscal quarter ended June 30, 2013, compared to income from continuing operations of $149,943,000 ($1.38 per diluted share) from operating revenues of $819,785,000 during last year's third fiscal quarter, and income from continuing operations of $151,067,000 ($1.39 per diluted share) from operating revenues of $838,309,000 during the second fiscal quarter of 2013.
Sign-up for Helmerich & Payne, Inc. Announces Third Quarter Earnings investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry Date to Helmerich & Payne, Inc. Announces Third Quarter Earnings
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity